b-catenin is a multifunctional protein involved in both cadherin-mediated adhesion and the wnt signaling cascade. Mutations in exon 3 of b-catenin have been identified in many cancers. In addition to disruption of key serine and threonine residues, mutations are frequently reported in other residues in exon 3 that are not kinase substrates. The most frequently mutated nonserine/ threonine residues are D32 and G34. Since D32 and G34 are part of the ubiquitination destruction motif, DSGUXS, we hypothesize that this motif may contribute to disruption of b-catenin homeostasis and lead to cellular transformation. We demonstrate that the mutants D32A and G34A exhibit no change in phosphorylation by GSK3b, but display reduced ubiquitination compared to wild-type and S33A mutant b-catenin. To assess the functional implications of these mutations, we created stable MDCK cell lines expressing these constructs. We found that stable cell lines harboring D32A-mutated b-catenin were highly transformed, while S33A and G34 demonstrated only weak transforming properties in our assays. Despite altered ubiquitination status and increased transformation, the D32A mutant cell line does not display transcriptional activation of standard target genes. Therefore, D32A mutation may mediate transformation by an alternative b-catenin-mediated signaling pathway.
Introduction b-catenin is an intracellular protein that participates in both cadherin-mediated adhesion and as a signaling molecule. In the adherens junction, b-catenin mediates the linkage between transmembrane cadherin molecules and cytosolic a-catenin. b-catenin is essential for the structural integrity of this complex. b-catenin also plays a role in cell signaling as part of the wnt signaling cascade (Polakis, 2000) . Normal 'canonical' wnt signaling begins when the wnt ligand binds its receptor complex, Frizzled (Frz) and low-density lipoproteinrelated protein 5/6 (LRP 5/6), which activates the cytoplasmic protein-dishevelled (Dsh). Dsh inactivates the serine/threonine kinase GSK3b by disrupting its interaction with the scaffolding protein axin/conductin. Disruption of GSK3b allows b-catenin to avoid phosphorylation and creates a stabilized cytosolic pool of b-catenin that is translocated to the nucleus where it acts as a cofactor for the TCF/LEF transcription factors. b-catenin and TCF/LEF activate wnt-responsive target genes such as cyclin D1, MMP7, COX2 and others (Lustig and Behrens, 2003) .
In the absence of the wnt signal, GSK3b complexes with adenomatous polyposis coli (APC), axin/conductin and casein kinase 1 (CK1), binds b-catenin and facilitates its phosphorylation on the serine and threonine residues in a hierarchical manner. CK1 phosphorylates S45, followed by GSK3b's sequential phosphorylation of T41, S37 and S33. Phosphorylated b-catenin binds the E3 ubiquitin ligase b-TrCP and undergoes proteosomal degradation, preventing its accumulation and transcriptional activity. Alterations to members of the regulatory complex, APC or axin, b-TrCP or b-catenin itself, lead to inappropriate stabilization of b-catenin and its participation in transcriptional activation (Polakis, 2002; Lustig and Behrens, 2003) .
Exon 3 is the hotspot for mutation because it contains the consensus sequences for multiple kinases, including GSK3b, CK1, CK2 and IkBa kinases and a ubiquitination consensus sequence. Mutation of these consensus sequences occurs in a variety of benign and malignant human tumors. Others and we have surveyed the literature on exon 3 mutations and ranked them by frequency. The exon 3 serine and threonine residues (S37, T41 and S45) are the most common mutations. However, two nonphosphorylatable residues, D32 and G34, rank within the top six mutations identified in human tumors, as well (Provost et al., 2003) . Since D32 and G34 flank residues that are phosphorylated by GSK3b (S29, S33, S37 and T41), their disruption in human tumors is generally believed to cause oncogenic activation of b-catenin. Recently, Al-Fageeh and coworkers showed that D32 mutations result in the activation of signaling as assessed by the TOPFLASH assay, and that some mutations also affected S33 phosphorylation without affecting phosphorylation at S37, T41 or S45, as assessed by phospho-specific b-catenin antibodies. Further, they suggest that mutation of residue D32 does not dramatically effect ubiquitination, despite it being the first residue in the conserved ubiquitination consensus sequence (Al-Fageeh et al., 2004) .
Ubiquitination takes place via an enzyme cascade, resulting in covalent attachment of ubiquitin molecules to lysine residues on target substrates. Polyubiquitin chains are then assembled to tag the substrate for rapid, energy-dependent degradation by the 26S proteasome. Ubiquitination of b-catenin is phosphorylation dependent and utilizes the Skp1/Cul1/Roc1/F-box SCF E3 ligase complex. The F-box ligase for b-catenin is b-TrCP. Like other F-box family members, b-TrCP has two distinct domains, the F-box, which binds Skp1, and the WD40 repeats, which bind the substrate. Structural modeling has confirmed that b-catenin invariant residues in the destruction motif, D32, S33, G34 and S37, directly bind the WD40 domain of b-TrCP1 (Wu et al., 2003) . Mutation of the residues in b-TrCP1 that interact with b-catenin's DSGFXS motif resulted in disruption of the b-TrCP1-b-catenin interaction and subsequent ubiquitination. However, disruption of the substrate DSGFXS motif in b-catenin was not evaluated in this study (Wu et al., 2003) .
IkBa shares the DSGFXS destruction motif with b-catenin. IkBa utilizes the same phosphorylationdependent SCF machinery and specific F-box ligase, b-TrCP1. Site-directed mutagenesis of the destruction motif in IkBa revealed the importance of not only the phosphorylatable serine residues but also the aspartic acid and glycine residues in the destruction motif. Substitution of D31 (aspartic acid, IkBa residue 31) to alanine completely eliminates the ability of IkBa to bind FWD1 (mouse homolog b-TrCP ligase) and subsequent ubiquitination of IkBa. Substitution of G33 (glycine, IkBa residue 33) to alanine resulted in a decrease in binding to FWD1 and decreased ubiquitination, although not a complete elimination. When D31 was changed to glutamic acid to mimic the phosphorylation of the residue, binding of the ligase and ubiquitination were almost completely restored (Hattori et al., 1999) . Thus, the relative importance of the nonphosphorylatable residues in this consensus sequence was demonstrated for IkBa.
While naturally occurring mutations in the destruction motif of IkBa in human tumors are unreported, mutations in the destruction motif of b-catenin are frequently identified. Therefore, mutations of D32 and G34 of b-catenin were tested for alteration of b-catenin ubiquitination status. Since the SCF b-TrCP complex depends upon phosphorylation of its substrate, we tested the mutants D32A and G34A in an in vitro kinase assay for phosphorylation by GSK3b. As stabilization of b-catenin is important for its role as an oncogene, D32 and G34 mutations were also evaluated for cellular transformation in assays of growth and invasion. Our results indicate that mutation of D32 and G34 to alanine greatly reduced the ability of b-catenin to be ubiquitinated by b-TrCP1, compared to WT and S33A mutants. However, neither of the mutants was impaired in their ability to act as substrates for GSK3b, suggesting that changes in ubiquitination status were not due to decreased phosphorylation of the b-catenin mutant substrate. Further, D32A mediated a transforming phenotype in multiple assays for growth and migration in stable MDCK cell lines. Evaluation of stable cell lines for transcriptional activation of b-catenin target genes revealed that none of the stable cell lines had altered transcriptional status of target genes. Taken together, these data suggest that mutation of the nonphosphorylatable residue D32A in b-catenin is capable of stabilizing b-catenin and mediating its oncogenic activity without altering the phosphorylation status of S33.
Results

Disruption of the DSGFXS motif causes alterations to b-catenin ubiquitination status
Ubiquitination of b-catenin targets it for degradation by the 26S proteasome (Aberle et al., 1997) . Degradation of b-catenin controls the levels of free, cytosolic and signaling-competent b-catenin. DSGFXS, the destruction motif for ubiquitination of b-catenin, is shared with IkBa, IkBb, IkBepsilon, plakoglobin (Orford et al., 1997) , Vpu (Besnard-Guerin et al., 2004) and Emi1 (Guardavaccaro et al., 2003) . IkBa site-directed mutagenesis revealed that mutation to alanine of the aspartic acid residue (D31A) abolished both recognition by b-TrCP1 and ubiquitination. Mutation of IkBa glycine residue to alanine (G33A) reduced but did not eliminate interaction with b-TrCP1 or ubiquitination (Hattori et al., 1999) . While mutations of IkBa on residues in the ubiquitination consensus sequence in human tumors are not reported in the literature, this sequence is disrupted frequently in b-catenin. Therefore, we tested whether point mutants within this sequence exhibit the same disruptions as IkBa.
Constructs of HA-tagged b-TrCP1, HA-tagged ubiquitin and flag-tagged b-catenin were transiently transfected into HEK 293T cells. At 24 h post-transfection, lysate was made and immunoprecipitated using anti-flag antibody to identify exogenous b-catenin. Western blot analysis revealed higher molecular weight b-catenin bands, which corresponded to HA-tagged ubiquitin ( Figure 1a ). Wild-type (WT) b-catenin served as a positive control and was normalized in the graphical representation of the level of ubiquitination (Figure 1b) . The double serine mutant S33S37A served as a negative control, since b-TrCP-mediated ubiquitination of b-catenin is phosphorylation dependent. Figure 1 demonstrates that S33S37A was ubiquitinated at very low levels. D32A and G34A were greatly reduced compared to WT b-catenin in their degree of ubiquitination. The S33A single point mutant exhibited an increase in the amount of ubiquitin, as compared to WT b-catenin. These results were reproducible over multiple
transfections. Lysate was normalized to total flag levels to control for transfection efficiency and variability in plasmid expression levels ( Figure 1b) . b-catenin must be phosphorylated to interact with the ubiquitination machinery of the cell. Both D32 and G34 are contained within the GSK3b kinase consensus sequence in exon 3 of b-catenin. Further, D32 and G34 are directly adjacent to S33, a direct serine target of GSK3b. To determine whether the mutant constructs disrupted phosphorylation by GSK3b, we performed an in vitro kinase assay using recombinant GSK3b. We found that both D32A and G34A b-catenin were phosphorylated similar to WT (Figure 2) . A greater than 50% reduction in phosphorylation was seen in the QUAD (S33AS37AT41AS45A) and S33AS37A mutants, as expected for partial serine/threonine mutants of b-catenin. Since there are multiple kinase sites that are substrates for GSK3b, no b-catenin mutants showed complete loss of phosphorylation similar to the a-catenin control. For similar reasons, the S33A single mutant also did not show appreciable loss of phosphorylation. The D32 residue on b-catenin appeared to have an increase in phosphorylation by GSK3b, but this difference was not statistically significant from WT in three independent assays evaluated. a-Catenin was used as a negative control and exhibited only background levels of phosphorylation.
Since the phosphorylation status of D32A and G34A is normal, we concluded that alterations to the ubiquitination status of b-catenin are due to its interaction with the ubiquitin machinery and its function as a ubiquitin substrate. Since both D32A and G34A have altered ubiquitination status, we next wanted to determine if disruption of these residues would predict transformation potential in cells. To do this, we made stable cell lines for each of the point mutants in the nontransformed epithelial cell line, MDCK. The stable cell lines were assessed for alterations in growth, motility and invasion.
The generation of MDCK stable cell lines with mutant b-catenin
The nontransformed, epithelial cell line MDCK was used to generate stable cell lines harboring b-catenin point mutants for D32A, S33A and G34A. MDCK cells were chosen for their ease of transfection and because they contain intact cadherin and wnt signaling components. Mutant b-catenin was flag tagged to distinguish it from endogenous WT b-catenin. The presence of endogenous WT b-catenin mimics human tumors, which exhibit both mutant and WT protein, and thus no attempt was made to alter the endogenous protein.
Repeated attempts to stabilize a WT overexpressing clone failed due to cellular toxicity, thus vector-only cells were used as a control. Cells were maintained in neomycin-containing media to prevent loss of expression of exogenous b-catenin.
There was no alteration in the localization of b-catenin in the cell lines ( Figure 3a) . b-Catenin stained primarily at the membrane in confluent cells. As previously observed in stable MDCK cells, consistent heterogeneous staining was exhibited in the clones (Provost et al., 2003) . In contrast to the flag staining in mutants, vector-only cells exhibited perinuclear, nonspecific background staining. As membranous flag staining was observed in the stable cell lines, we evaluated mutant b-catenin's ability to interact with members of the adherens junction. In both co-immunoprecipitation and pull-down assays, there was no change in mutant b-catenin's ability to interact with a-catenin or E-cadherin (data not shown). (S33AS37AT41AS45A) and S33AS37A demonstrated a greater than 50% reduction in phosphorylation compared to WT b-catenin, as expected. D32A appeared to have an increase in phosphorylation by GSK3b, but it was not statistically significant. S33A and G34A were comparable to WT b-catenin. Experiments were repeated in triplicate
To evaluate flag-tagged, mutant b-catenin levels in the transfected cells, both RNA and protein levels were determined. Northern blots confirmed the presence of the transcript for flag-tagged b-catenin at levels comparable to the endogenous transcript ( Figure 3c ). To distinguish between the 92 kDa endogenous b-catenin and the 94 kDa flag-tagged b-catenin mutants, low percentage SDS-PAGE was performed. Western blotting for flag revealed the presence of exogenous b-catenin in the stable cell lines. (Figure 3b ). Thus, by both Northern and Western blot, the presence of mutant flag-b-catenin was detected. The best expressing clones were used in transformation assays.
All constructs mediate growth independence in soft agar, but only the D32A cell line demonstrates morphologic changes of cysts All the mutant cell lines were capable of mediating anchorage-independent growth in soft agar and formed significantly more colonies than vector ( Figure 4a ). The structure of the colonies that formed in soft agar was assessed by H&E staining of colonies in cross-section. Untransfected MDCK cells formed cysts of polarized cells. Both S33A and G34A formed complex cystic structures consisting of multicellular polar arrangements similar to control. However, D32A displayed a unique morphological variation in soft agar. While polarized, multichambered cysts formed, breakdown of this structure occurred in localized areas of the cyst and resulted in nonpolarized growth into soft agar (Figure 4b ). The consistent loss of cystic architecture led us to further characterize this mutant clone using invasion and migration assays.
The migratory phenotype of the mutant cell lines
Increased migration and invasive potential are markers of cellular transformation. Based on outgrowth of the D32A colonies in the soft agar assay, invasion assays were undertaken (Figure 5a ). The cells were allowed to invade collagen I-coated Boyden chambers for 24 h. The Boyden filters were then fixed, stained and counted for migration through the matrix and filter. D32A demonstrated increased invasion. Additionally, S33A demonstrated increased invasion through the collagen I matrix. G34A did not invade above control levels.
MDCK cells are known to form polarized structures in collagen I gels (Hotary et al., 2000) . Since increased invasion was seen in D32A and S33A, and architectural changes were observed in soft agar for D32A, colony structure was assessed in three-dimensional collagen matrices. Cells were grown in three-dimensional collagen I gel pellets for 8 days, fixed and stained for morphologic examination. As reported previously, srctransformed MDCK cells show a highly altered morphology, demonstrating loss of polarity and structure (Zou et al., 2002) , but even in identical conditions, all of the b-catenin mutants were able to form cystic structures similar to vector (Figure 5b ). Thus, unlike colony growth in soft agar, the D32A mutant cell line maintained regular structural morphology in collagen I gels. Thus, outgrowth in soft agar and invasion through the collagen matrix in Boyden chambers may measure two different matrix-dependent behaviors of these cells. Another measure of migration is wound healing. Wounded monolayers of cells grown on tissue culturetreated plastic revealed an increase in the rate of wound closure for D32A but not for S33A. Thus, for S33A, matrix may be essential to mediate invasive potential, As cells invade through collagen I matrix, they are evaluated for structure in three-dimensional collagen I matrix. Cells are grown in rat tail collagen I gel for 8 days and are assessed for cystic architecture. Untransfected cells show small structures, while mutants all show larger cysts with hollow centers. All the mutants have similar cystic structure in the collagen I gels. Pictures Â 100 (c). Wounding assay. Cells are evaluated for their ability to migrate into a cell-free area following physical disruption of the monolayer. Only D32A shows statistical significance by t-test. Each wounding assay is performed in triplicate D32 mutation in b-catenin E Provost et al while D32A is able to increase migration under multiple conditions (Figure 5c ).
D32A cell line promotes proliferation at high cell densities
In addition to changes in invasion and wound healing migration, contact inhibition at confluence is a property of normal cells that is lost during transformation. Transformed cells will continue to proliferate at high cell densities, lacking normal growth inhibitory controls. Growth curves and cell shedding assays were conducted to assess the ability of the stable, mutant b-catenin cell lines to overcome contact inhibition. At the steady-state phase of growth, D32A had increased numbers of cells present compared to vector-transfected cells (Figure 6a ). G34A and S33A were equivalent to vector. A cell shedding assay was conducted to determine whether the cells were still actively dividing in the steady-state phase of the growth curve.
Cell shedding is another measure of proliferation at high cell density. On day 13 of the growth curve when the cells reached a steady state of confluence, the number of cells shed over 24 h was evaluated (Figure 6b) . Again, D32A shed significantly more cells, while S33A shed fewer cells than vector. G34A also shed more cells than vector, but did not have a higher density of cells. Thus, G34A may have increased cell turnover and proliferation at confluence, but did not demonstrate overgrowth of cells associated with the monolayer. However, D32A demonstrated both an increased number of cells associated with the monolayer at confluence and an increased number of cells shed from the monolayer.
This experiment was only consistently reproduced when the cells achieved steady-state confluence. To determine if the shed cells were viable, the assay was conducted on day 13 for 6 h and the shed cells were replated. The replated cells did not attach to the plate and grow (data not shown). Thus, none of the mutations confer viability in suspension when shed from the monolayer, but rather reflect a continued production and turnover of the monolayer in confluent cells.
Mutation of residues 32-34 does not alter expression of some downstream wnt targets
Canonical wnt signaling as a result of b-cateninmediated transcriptional activation results in expression of a large number of genes. Others and we have shown that mutations in S37, T41 and S45 result in alteration of cyclin D1, myc, id-2 and Cox2 and other gene levels (Provost et al., 2003) . Although it has recently been reported that some D32 mutants can activate transcription in the TOPFLASH assay, actual gene expression has been less well documented. Here, we evaluated a series of target genes for transcriptional activation for the D32A, S33A and G34A MDCK stable cell lines. We have observed that S45A and T41A cell lines modify transcriptional levels of cyclin D1, myc, id-2 and Cox2 (Provost et al., 2003) ; therefore, these genes were tested with the residues 32-34 mutants. Figure 7 shows that none of these target genes changed their expression, even though these genes are altered by T41A and S45A b-catenin mutations (Figure 7a-d) .
Discussion
Although many tumors have mutations in residues that are not phosphorylated, it was presumed that these mutants modulated b-catenin-mediated signaling through effects on phosphorylation of adjacent residues. However, this has not previously been directly demonstrated. Our data demonstrate that D32A and G34A, two residues frequently mutated in b-catenin, are important for b-catenin ubiquitination, but are not required for phosphorylation by GSK3b. Furthermore, we show that the D32A b-catenin mutation mediates a transformed phenotype. The residues including and surrounding S33 are part of a multifunctional region of b-catenin. D32, S33 and G34 are part of the consensus sequence for b-TrCP binding and for GSK3b, and IkBa kinases. Disruption of multiple regulatory domains in b-catenin may carry weighted and combinatorial responses. The cell line harboring the D32A mutation transforming abilities may arise from its disruption of multiple pathways. However, the DSGFXS motif is responsible for phosphorylation-dependent interaction of b-catenin with b-TrCP E3 ligase. This interaction is essential for appropriate targeting of b-catenin to the proteasome for degradation. Since D32A resulted in decreased levels of ubiquitination of b-catenin, we postulate that this stabilization of D32 resulted in transformation of the epithelial MDCK cell line.
While ubiquitination was greatly reduced in the assay for S33S37A, D32A and G34A, some residual ubiquitin character was consistently seen as background in this assay. This may be due to leakiness in the assay or because of other, nonphosphorylation-dependent ubiquitination machinery in the cell. Specifically, the p53-activated Siah/SIP/SCF/Ebi pathway has been shown to degrade b-catenin, but does not rely on phosphorylation of its N-terminus (Liu et al., 2001; Matsuzawa and Reed, 2001 ). The assay employed in the ubiquitination experiments did not test whether any activation of p53 occurred, or if Siah/SIP/Ebi-mediated ubiquitination played a role in ubiquitination of b-catenin. The relative contribution of these two pathways to b-catenin degradation is still not well understood, but may contribute to overall regulation of b-catenin in the cell.
While IkBa and b-catenin contain the same ubiquitin consensus sequence, there are differences in the ubiquitination of these proteins. While mutation of the aspartic acid residue in both b-catenin and IkBa results in loss of ubiquitination, mutation of glycine in IkBa reduces ubiquitination but does not eliminate it (Hattori et al., 1999) . In contrast, G34A on b-catenin greatly reduced ubiquitination as did D32A. These differences between the b-catenin and IkBa systems may be due to variability in experimental procedure, or because of other differences between the two proteins.
In this study, D32A demonstrated transformation in all assays. D32A mutation altered the morphology of colonies in soft agar, increased invasion and migration in a wounding assay and increased growth and cell shedding at confluence. However, Northern blot analysis of several downstream target genes of b-catenin, including cyclin D1, Cox2, id-2 and myc, did not demonstrate any changes in transcriptional levels ( Figure 7) . Therefore, despite avoiding ubiquitination, neither D32A nor G34A stable cell lines were able to activate some of the canonical TCF/LEF target genes.
Several possibilities for the lack of transcriptional activation of D32A and G34A cell lines exist. First, the relative importance of these genes in canine cells may not reflect their role in human cells with deregulated b-catenin. Likewise, it is possible that the limited nature of this study did not reveal targets of D32A, S33A or G34A transcriptional activation. This possibility must be considered due to the broad and constantly growing number of genes found to be activated by b-cateninmediated signaling in a wide range of model systems. Furthermore, work published while this manuscript was in preparation reveals that some mutations at D32 activate transcription in the TOPFLASH assay (AlFageeh et al., 2004) . However, it may be that these residues are not capable of creating signaling-competent b-catenin and that D32A mediates transformation by nontranscriptional mechanisms.
In conclusion, based on assays for anchorageindependent growth, invasion, migration and proliferation, D32A represents a highly transforming mutation.
Although both D32A and G34A demonstrated a decrease in ubiquitination, only D32A mediates transformation. Work on the role of D32 and G34 with regard to alteration of kinase activity is ongoing and may provide a clearer picture of their role in b-cateninmediated transformation.
Materials and methods
Site-directed mutagenesis
Mutants were generated using two different kits. Mutant S33A was made with the MORPH site-specific plasmid DNA mutagenesis kit (Eppendorf 5 0 , Boulder, CO, USA). D32A, G34A, S33AS37A and QUAD (S33AS37AT41AS45A) mutants were produced using Quik-change PCR-based mutagenesis kit (Stratagene, Cedar Creek, TX, USA). Template for mutagenesis reactions in both kits was WT full-length b-catenin in pcDNA3 (Invitrogen, Carlsbad, CA, USA) with a flag-tag directly upstream of the b-catenin start codon. Mutants were confirmed by direct sequencing (Keck facility, Yale University, New Haven, CT, USA). All target codons were changed to alanine. Following confirmation of the sequence, mutant plasmids were transformed into DH5a bacteria. Large preparations of plasmids for transfection were generated by maxi prep kits (Qiagen, Valencia, CA, USA).
Cell lines used
HEK 293T cells were a gift of the Fu Lab, originally purchased from ATTC (Manassas, VA, USA). HEK 293 were grown in DMEM supplemented with 10% FBS and 1% penicillin/ streptomycin (Life Technologies Inc., Grand Island, NY, USA). MDCK cells were obtained from ATCC. MDCK cells were maintained in DMEM supplemented with 5% FBS and 1% penicillin/streptomycin. Mutant stable cell lines were maintained in DMEM supplemented with 5% FBS, 1% penicillin/streptomycin and 500 mg/ml G418 (Life Technologies Inc., Grand Island, NY, USA).
Transient transfection and immunoprecipitation
HEK 293T cells were plated onto 70-80% confluence on 10 cm tissue culture-treated Falcon dishes (Becton Dickinson and Co., Lincoln Park, NJ, USA). Cells were transfected using calcium phosphate. Briefly, HEK 293T cells had fresh 25 mM chloroquine-containing media added to them 5-10 min prior to the addition of DNA solution. DNA solution contained 5-10 mg of DNA in a 15 ml Falcon tube, followed by sterile water and 61 ml of 2 M CaCl 2 to a final volume of 500 ml. An equal volume of 2 Â HEPES-buffered saline (pH 7.0) was bubbled through the DNA solution and added dropwise to cells. Nonchloroquine-containing media were replaced 8-12 h following transfection.
Transiently transfected cells were harvested 18-24 h later using 0.5% Triton lysis buffer (50 mM Tris-HCl (pH 7.6), 300 mM NaCl and 0.5% Triton X-100). Lysates were cleared by centrifugation, 14 000 r.p.m., 41C for 15 min and quantitated using the Bio-rad reagent (Biorad, Hercules, CA, USA). Total protein was immunoprecipitated with either polyclonal flag antibody to capture exogenous b-catenin constructs or HA monoclonal antibody to capture exogenous CKIIalpha constructs. Briefly, lysates were precleared with recombinant protein A-sepharose 4B beads (Zymed, San Francisco, CA, USA) for 1 h at 41C, followed by 1 h of immunoprecipitation with appropriate antibodies. Recombinant protein A beads (Zymed, San Francisco, CA, USA) were added for 1 h and the precipitates were washed three times with 1% Triton buffer (20 mM Tris-HCl (pH 8.0), 5 mM EDTA, 150 mM NaCl, 1% glycerol, 1% Triton X-100). Upon aspiration of the final wash, beads were boiled with 2 Â loading buffer and loaded onto 15 cm, 6% SDS-PAGE gels. Gels were run, cooled to 151C at constant amps for 5-7 h and transferred to 0.45 mm Hybond nitrocellulose (Amersham Biosciences, Pistcataway, NJ, USA). Membranes were then probed by Western blotting.
Stable cell lines
Subconfluent MDCK cells were transfected with Lipofectamine 2000 (Life Technologies Inc., Grand Island, NY, USA) on 10 cm plates with 2 mg DNA : 6 ml of Lipofectamine 2000. At 2 days post-transfection, the cells were split 1 : 20 and growth media containing 500 mg/ml G418 (Life Technologies Inc., Grand Island, NY, USA) were added. Cells were selected in G418 for 10-12 days. Colonies were picked using colony rings and candidate clones screened by immunohistochemistry and Western blotting. The clone that expressed the highest levels of mutant protein was selected for propagation. This was carried out to more accurately reflect real human tumors since b-catenin mutations are almost never homozygous and, presumably, a low level of mutant protein would have lesser effects than higher levels would. Clones are maintained in G418-supplemented growth media to prevent loss of expression of the gene over multiple passages of the clones.
Extraction total protein from MDCK cells
Triton lysate (1%) of cultured stable cells was made 3 days postplating on six-well Falcon plates (Becton Dickinson and Co., Lincoln Park, NJ, USA). Lysate concentration was measured using Biorad reagent (Biorad, Hercules, CA, USA) and 20-40 mg total lysate loaded onto 15 cm, 6% SDS-PAGE gels run at 151C for 6 h. Gels were transferred in high glycine transfer buffer (25 mM Tris-HCl (pH 8.0)-glycine, 20% methanol) to 0.45 mm Hybond nitrocellulose membrane (Amersham Biosciences, Pistcataway, NJ, USA) on the Genie transfer apparatus (Idea Scientific, Minneapolis, MN, USA).
Western blot
Membranes were blocked in 1% BSA-TBS-0.5% Tween for 30 min. Primary antibody, flagged (Sigma, St Louis, MO, USA) at 1 : 1000, b-catenin (Transduction Labs, BD Biosciences, San Diego, CA, USA) at 1 : 10 000 or HA (Covance, Berkley, CA, USA) at 1 : 1000, was added to fresh 1% BSA-TBS-Tw and incubated at room temperature for 1 h. Following washing with TBS-0.5% Tween, horseradish peroxidaseconjugated goat anti-mouse secondary antibody (Pierce, Rockford, IL, USA) was incubated with the blots at 
RNA and Northern blot
RNA was made by CsCl purification. Briefly, T75 flasks 70-80% confluent were lysed with guanadine thiocyante (GITC) (4 M GITC, 25 mM sodium acetate, filtered 0.45 mm (Nalgene, Rochester, NY, USA)). Lysate was applied to a 5.7 M CsCl (5.7 M CsCl, 25 mM sodium acetate, filtered 0.45 mm (Nalgene, Rochester, NY, USA)) cushion in polyallomer centrifuge tubes (14 Â 89 mm 2 Beckman Coulter, Jersey City, NJ, USA). Samples were spun in an SW40.1 ultracentrifuge 16-18 h at 28 000 r.p.m., 201C. The following day, pellets of RNA were washed twice in ETS (1 mM EDTA, 10 mM Tris-HCl (pH 7.4), 0.1% SDS) buffer, ethanol precipitated and resuspended in DEPC water. It was quantified at 260 nm on a spectrophotometer and 15 mg was added to 25 ml of loading buffer, boiled, chilled and loaded onto a denaturing 0.6% denaturing RNA gel. Gels were run in 1 Â MOPS (pH 7.0) (20 mM MOPS, 5 mM sodium acetate, 1 mM EDTA) for 4 h. Gels were transferred, top-down, with alkaline transfer buffer (3 M NaCl, 8 mM NaOH (pH 11.4), 0.2 mM sarkosyl) for 2 h onto Duralon-UV membrane (Stratagene, Cedar Creek, TX, USA). Following transfer, the membrane was neutralized (0.2 M sodium phosphate buffer (pH 6.7)) and UVcrosslinked in a Hoefer UVC 500 (Hoefer, San Francisco, CA, USA). Membranes were prehybridized at 681C for 1h in ExpressHyb (Clontech, Palo Alto, CA, USA), 10 mg/ml salmon sperm DNA (Stratagene, Cedar Creek, TX, USA), and b-catenin was isolated from plasmid DNA by restriction digest and radiolabeled with [a-32 P]dCTP using Ready-To-Go DNA labeling beads (Amersham Biosciences, Pistcataway, NJ, USA). GAPDH was generated using G3PDH control amplimer set (Clontech, Palo Alto, CA, USA). Probe was boiled and added to prehybridization buffer at 1-2 Â 10 6 counts/ml. Blots were hybridized for 1 h at 681C, and then washed three times at room temperature in Buffer I and twice at 551C in Buffer II (Buffer I: 2 Â SSC, 0.05% SDS; Buffer II: 0.1 Â SSC, 0.1% SDS). Blots were then exposed to film between 1 and 24 h at À801C.
Quantitation of bands on gels
Gels were quantified using TotalLab 1-D analysis software (Nonlinear Dynamics, UK) or NIH image software. The density of bands is measured in pixel concentration and given in arbitrary units.
Immunohistochemistry
MDCK stable cells were grown on four chamber slides (Becton-Dickinson, Mountainview, CA, USA) and fixed 48 h postplating with fresh 4% paraformaldehyde/TBS. Cells were permeabilized with 0.5% Triton X-100/TBS and blocked in 1% BSA-TBS. Cells were then exposed to primary antibody in 1% BSA/TBS solution. b-Catenin antibody was an in-house polyclonal, YR6, at 1 : 500. Flag antibody was an M2 monoclonal antibody (Sigma, St Louis, MO, USA) at 1 : 1000. Secondary antibodies were GAR-Alexa488 (b-catenin), and GAM-cy3 (flag-tagged b-cat) (Amersham Biosciences, Pistcataway, NJ, USA). Secondary antibodies were diluted in TBS-Tween (0.5%) wash buffer. Cells were mounted in immunomount media (Shandon, Pittsburgh, PA, USA). Cells were visualized using fluorescence microscopy. Pictures were taken at Â 200.
Ubiquitination assay
HEK 293T cells were transiently transfected with 5-10 mg of pBSSK-HA-ubiquitin (gift from Hui Zhang, Yale University, Department of Genetics), pUNI10-HA-b-TrCP1 (gift from WJ Harper, Baylor College of Medicine) and flag-tagged b-catenin constructs, using standard calcium phosphate methods. At 24 h post-transfection, cells were lysed using 0.5% Triton buffer and and 1 mg total protein was immunoprecipitated with polyclonal flag antibody (Sigma, St Louis, MO, USA). Sample buffer (10-20 ml) was loaded onto 6% SDS-PAGE gels and Western blotted for b-catenin (Monoclonal Transduction Labs Palo Alto, CA, YSA), HA (Monoclonal Covance, Berkley, CA, USA) or flag (monoclonal, M2, Sigma) antibodies. Levels of ubiquitination were assessed by Total Lab and Prism software.
Kinase assays
GSK3b kinase assays were conducted using recombinant GSK3b (NEB). Briefly, reactions contained 10 mg GSTb-catenin substrate eluted from beads by glutathione (pH 8.0), 1 Â sample buffer (20 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 and 5 mM DTT), 50 mM cold ATP and 15 mCi [g-32 P] and 15 U GSK3b. Reactions were conducted for 30 min at 301C according to the manufacturer's protocol. To stop the reaction, boiling 2 Â sample buffer was added and the samples were loaded onto a 7.5% SDS-PAGE gel and run at constant amps. Gels were then transferred to nitrocellulose membranes and stained with 1 Â Ponceau stain (Sigma-Aldrich, St Louis, MO, USA) and exposed to film. Density of the bands was quantified using Total Lab Software (UK).
Soft agar assay
A total of 5000 cells/well were suspended in DMEM/5% FBS and 1% agarose PBS and plated onto six-well Falcon plates (Becton Dickinson and Co., Lincoln Park, NJ, USA) previously coated with 0.6% agarose cushions. After gelling for 20 min, MDCK growth media were added and changed every 2-3 days for 14 days. Cells were stained with 0.005% crystal violet/95% ethanol for 1 h at room temperature. Pictures of multiple fields of colony formation were photographed and the number of colonies counted using NIH Image. Six fields were counted for each assay and s.e.m. was generated and clones were tested against vector by Student's t-test (Prism software, GraphPad, San Diego, CA, USA). Following image capture, soft agar cushions were fixed in buffered formalin overnight paraffin embedded. Blocks were sectioned, H&E stained and pictures taken under Â 400 on an inverted scope.
Three-dimensional collagen I assay
Rat tail collagen I was obtained from BD Biosciences (San Diego, CA, USA). Briefly, collagen I matrix final concentration of 2.2-2.4 mg/ml was made by mixing 10 Â DMEM (Life Technologies Inc., Grand Island, NY, USA), and 0.02 N acetic acid to volume and the pH was adjusted to 7.4 with 1 M NaOH. Then, the stable cells, previously trypsinized, washed and pelleted, were resuspended at 500 000 cells/ml in collagen I solution. Collagen I cell suspension was dripped onto p60 Falcon Petri dishes (Becton Dickinson and Co., Lincoln Park, NJ, USA) and allowed to set at 371C, 5% CO 2 for 20 min. Complete media were gently added and changed every 2 days for 8 days. On the 8th day, collagen I droplets were removed with forceps and fixed in formalin. Droplets were then D32 mutation in b-catenin E Provost et al embedded in paraffin, sectioned and H&E stained. Pictures were taken on a dissecting scope at Â 100.
Invasion assay
Type 1 collagen: Type 1 Rat tail collagen was purchased from BD Bioscience (San Diego, CA, USA). All steps in the preparation of collagen were performed on ice in a sterile cell culture laminar flow cabinet. The collagen was diluted to 1 mg/ml with 0.1 M acetic acid; 10 Â DMEM was diluted to a final concentration of 1 Â DMEM. The pH of the collagen adjusted to 7.5-8.0 with dropwise addition of NaOH. The collagen was used to coat 12-well format, 8 mm pore size cell culture inserts (Falcon, Becton Dickinson and Co., Lincoln Park, NJ, USA). These inserts were placed in 12-well cell culture plates, which act as the reservoir for the FBS serum chemoattractant. The surface area of each insert is 0.9 mm 2 . In all, 50 mg of the prepared type I collagen was pipetted onto each cell culture insert. The inserts were dried overnight at room temperature and then stored at 41C.
The prepared collagen inserts were rehydrated by the addition of 250 ml of serum-free DMEM cell culture medium for 1 h at room temperature. The serum-free DMEM was removed just prior to the addition of cells. A total of 25 000 cells were plated onto each cell culture insert. Cells were seeded in serum-free DMEM and serum-free DMEM was also placed into the reservoir. The cells were incubated overnight in a 371C incubator, 5% CO 2 . After the overnight incubation, fresh serum-free medium was added to the tissue culture inserts and DMEM containing 10% fetal calf serum was added to the reservoir as the chemoattractant. The cells were incubated for 24 h in a 371C incubator, 5% CO 2 . After 24 h, the inserts were removed and excess collagen and cells removed from the upper surface of the inserts with cotton swabs. Cells that had invaded the exposed under surface of the insert were fixed in ethanol and stained with Gills formula hematoxylin nuclear stain (Vector Labs, Burlingame, CA, USA). After staining, the insert membranes were removed and mounted on microscope slides and coverslipped. The number of invading cells was counted under a light microscope. Experiments were conducted in triplicate. Invasion assays were read, blinded, by two investigators. Results were averaged. Stable cell lines were compared to vector cell invasion and compared by t-tests.
Growth curve
Cells were plated at 300 000 cells/well on 12-well Falcon plates (Becton Dickinson and Co., Lincoln Park, NJ, USA) and fed every second day. On days 1, 3, 5, 7, 9, 11 and 13, cells were washed with PBS (Life Technologies Inc., Grand Island, NY, USA) and 0.25 mg/ml trypsin/EDTA was added to each well. Cells were resuspended to a single-cell suspension in growth media to quench trypsin. Then, they were read on a Z Series Coulter Counter (Beckman Coulter, Jersey City, NJ, USA). Each time point was plated in triplicate. S.e.m. was calculated for each time point and t-tested for significance (Prism software, GraphPad, San Diego, CA, USA).
Cell shedding assay
On day 12 of the growth curve, cells were washed thoroughly with PBS (Life Technologies Inc., Grand Island, NY, USA) and 1 ml of growth media was added. After 24 h, the shed cells were collected and read on the Coulter Counter, as in the growth curve. Each cell line was read in triplicate and t-tests were carried out to evaluate the significance (Prism Software, GraphPad, San Diego, CA, USA).
Wounding assay
The six-well Falcon plates (Becton Dickinson and Co., Lincoln Park, NJ, USA) were prepared for wounding assays by scoring the plates with a needle, so that wounds could be oriented for photos. After scratching the plates, they were washed with PBS (Life Technologies Inc., Grand Island, NY, USA) to remove any debris. A total of 1.5 Â 10 6 cells were plated in triplicate and allowed to adhere for 12-16 h at 371C, 15% CO 2 . Cells were wounded with a disposable pipette tip and pictures were taken at times 0, 2, 4, 6, 8 and 10 h. The change in area over 10 h was measured using NIH image and t-tests were conducted (Prism software, GraphPad, San Diego, CA, USA).
